PCV86 COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72805-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)72805-9/fulltext
Section Title :
Section Order :
371
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72805-9&doi=10.1016/S1098-3015(10)72805-9